GlassScriptPhysician profile
David Newman
NPI 1154863769
$14,839.92
in general payments reported to CMS, 2019-2025
12 companies · $2,950 in 2025
The $2,950 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2021: $3,003 · 2022: $2,281 · 2023: $5,139 · 2024: $1,173 · 2025: $2,950.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,692 · Food and Beverage: $2,570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,692.10 |
| Food and Beverage | $2,570.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $10,210.81 | 2019-2025 | Mako, Actishield, Restoration |
| Prodigy Surgical Distribution, INC. | $2,990.11 | 2022-2025 | |
| Arthrex, INC. | $1,231.56 | 2023-2025 | |
| Alphatec Spine, INC | $192.85 | 2025 | Other - Miscellaneous |
| Zimmer Biomet Holdings, INC. | $71.96 | 2019 | |
| Smith+Nephew, INC. | $28.48 | 2019-2022 | |
| Davol INC. | $27.02 | 2022-2025 | Arista |
| Pacira Pharmaceuticals Incorporated | $19.67 | 2022 | |
| Novo Nordisk INC | $18.76 | 2024 | Wegovy |
| Medtronic, INC. | $18.41 | 2023 | Mazor X System |
| Organogenesis INC. | $16.71 | 2021 | |
| Trice Medical, INC. | $13.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.